Johnson & Johnson (NYSE:JNJ) reported on Monday that its board of directors approved a common stock cash dividend of USD0.95 per share for the third quarter of 2019,the company .
With an ex-dividend date of 26 August 2019, the dividend will be paid on 10 September 2019 to shareholders of record at the close of business on 27 August 2019.
Johnson & Johnson together with its subsidiaries, researches and develops, manufactures and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical and Medical Devices.
The company was incorporated in 1887 and is based in New Brunswick, New Jersey, USA.
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Lilly declares Q2 2026 dividend
Collegium to acquire AZSTARYS from Corium Therapeutics
CVS Health announces quarterly dividend of USD0.665 per share